Overview of Controversial French Studies on Link Between Smoking and COVID-19

On April 21, 2020, two encouraging studies were released. The linked studies argued that nicotine can both protect tobacco users from COVID-19 and serve as a treatment option for the novel disease.

However, these studies are problematic and deeply concerning because

Media coverage has failed to identify the weaknesses of these studies, in some cases even prompting the panic-buying of nicotine. Studies such as these undermine the clear and consistent messaging on COVID-19 that is critical for public health and understanding.

Read more about how these smokescreen studies were conducted and why they can’t be trusted.

Read More